Foulds S, Wakefield C H, Giles M, Gillespie J, Dye J F, Guillou P J
Academic Surgical Unit, Imperial College of Science, Technology and Medicine, St Mary's Hospital Medical School, London, UK.
Br J Cancer. 1993 Sep;68(3):610-6. doi: 10.1038/bjc.1993.395.
mRNA for the suppressive epitope of p15E was found to be present in 24 of 30 samples of human colorectal cancer and in all four specimens of gastric cancer. mRNA for p15E was seldom seen in nonmalignant colonic or gastric mucosa but, when present, was associated with inflammatory or pre-malignant conditions of the digestive tract. Synthetic peptides derived from the conserved p15E sequence were found to suppress some aspects of the immune response implicated in anti-tumour activity. These data suggest that a p15E-related material with immunomodulatory properties is elaborated within human tumours, either by the tumour itself or as a normal component of the endogenous anti-tumour reaction.
在30份人类结直肠癌样本中的24份以及所有4份胃癌样本中,均发现了p15E抑制性表位的信使核糖核酸(mRNA)。在非恶性结肠或胃黏膜中很少见到p15E的mRNA,但一旦出现,则与消化道的炎症或癌前病变有关。源自保守p15E序列的合成肽被发现可抑制免疫反应中与抗肿瘤活性相关的某些方面。这些数据表明,一种具有免疫调节特性的p15E相关物质在人类肿瘤内产生,要么由肿瘤自身产生,要么作为内源性抗肿瘤反应的正常组成部分。